{
  "paper_metadata": {
    "pmid": "35686104",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on BRCA2 variants, including penetrance data from affected and unaffected carriers."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.2808_2811delACAA",
      "protein_notation": "p.Ala938ProfsTer21",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "63-year-old male",
        "phenotype": "Lobular breast carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 3,
        "affected_count": 1,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 33.33,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "III.4",
          "age_at_evaluation": 63,
          "age_at_onset": null,
          "age_at_diagnosis": 63,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Lobular breast carcinoma",
          "evidence_sentence": "The genetic analysis of BRCA1 and BRCA2 genes in this patient revealed the germline pathogenic variant c.2808_2811delACAA p.(Ala938ProfsTer21) in heterozygosity."
        },
        {
          "individual_id": "IV.8",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No disease manifestation reported",
          "evidence_sentence": "The BRCA2 pathogenic variant was also investigated in the patient\u2019s two sons (IV.8, IV.9), who inherited the same BRCA2 pathogenic variant."
        },
        {
          "individual_id": "IV.9",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No disease manifestation reported",
          "evidence_sentence": "The BRCA2 pathogenic variant was also investigated in the patient\u2019s two sons (IV.8, IV.9), who inherited the same BRCA2 pathogenic variant."
        }
      ],
      "functional_data": {
        "summary": "The pathogenic variant results in a premature termination codon predicted to cause a truncated or absent BRCA2 protein due to nonsense-mediated decay.",
        "assays": [
          "NGS",
          "Sanger sequencing"
        ]
      },
      "segregation_data": "The variant segregates with disease in the family.",
      "population_frequency": "0.0018% in the general European population",
      "evidence_level": "Strong evidence based on familial segregation and population frequency.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The variant is known to be one of the most common pathogenic variants in non-Ashkenazi Caucasians.",
      "key_quotes": [
        "The genetic analysis of BRCA1 and BRCA2 genes in this patient revealed the germline pathogenic variant c.2808_2811delACAA p.(Ala938ProfsTer21) in heterozygosity.",
        "This variant is known to be one of the most common pathogenic variants in non-Ashkenazi Caucasians."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding BRCA2 variants and penetrance were successfully extracted."
  }
}